Actovegin vs BPC-157
Overview
Actovegin is primarily a pain management peptide, while BPC-157 is used for bone & joint.
This page compares Actovegin and BPC-157 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Actovegin | BPC-157 | |
|---|---|---|
| Category | Pain Management | Bone & Joint |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5-10 ml | 250-500 mcg |
| Frequency | multiple weekly | daily |
| Reported benefits | Circulation-related pain relief, tissue oxygenation, healing support | Accelerated bone healing, cartilage repair, joint support |
| Reported side effects | Rare allergic reactions | Minimal side effects |
Key differences
Primary use. Actovegin is categorised under Pain Management, while BPC-157 falls under Bone & Joint. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Actovegin: not FDA-approved; treated as a research compound. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). BPC-157 is typically dosed at 250-500 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Actovegin and BPC-157 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Actovegin and BPC-157?
- Actovegin is primarily a pain management peptide, while BPC-157 is used for bone & joint. Actovegin is not FDA-approved; generally classified as a research compound, whereas BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Actovegin used for?
- Hypoxic pain and healing.
- What is BPC-157 used for?
- Bone and cartilage healing.
- Can you take Actovegin and BPC-157 together?
- Some users combine peptides within a single protocol, but stacking Actovegin and BPC-157 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Actovegin or BPC-157 FDA-approved?
- Actovegin is not FDA-approved; generally classified as a research compound. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026).